- Home
- Publications
- Publication Search
- Publication Details
Title
TGF-Beta as a Master Regulator of Diabetic Nephropathy
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 22, Issue 15, Pages 7881
Publisher
MDPI AG
Online
2021-07-23
DOI
10.3390/ijms22157881
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Loss of endothelial glucocorticoid receptor accelerates diabetic nephropathy
- (2021) Swayam Prakash Srivastava et al. Nature Communications
- Smad4 promotes diabetic nephropathy by modulating glycolysis and OXPHOS
- (2020) Jinhua Li et al. EMBO REPORTS
- Contribution of TGF-Beta-Mediated NLRP3-HMGB1 Activation to Tubulointerstitial Fibrosis in Rat With Angiotensin II-Induced Chronic Kidney Disease
- (2020) Kaimin Zhang et al. Frontiers in Cell and Developmental Biology
- Diverse Role of TGF-β in Kidney Disease
- (2020) Yue-Yu Gu et al. Frontiers in Cell and Developmental Biology
- Palmitate induces human glomerular mesangial cells fibrosis through CD36-mediated transient receptor potential canonical channel 6/nuclear factor of activated T cell 2 activation
- (2020) Yong Su et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- SMAD3 promotes autophagy dysregulation by triggering lysosome depletion in tubular epithelial cells in diabetic nephropathy
- (2020) Chen Yang et al. Autophagy
- Endoglin Promotes Myofibroblast Differentiation and Extracellular Matrix Production in Diabetic Nephropathy
- (2020) Tessa Gerrits et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Identification of Smad3‐related transcriptomes in type‐2 diabetic nephropathy by whole transcriptome RNA sequencing
- (2020) Qin Zhou et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- MicroRNA-29a Attenuates Diabetic Glomerular Injury through Modulating Cannabinoid Receptor 1 Signaling
- (2019) Chun-Wu Tung et al. MOLECULES
- Mineralocorticoid Antagonism and Diabetic Kidney Disease
- (2019) Yuliya Lytvyn et al. Current Diabetes Reports
- LRNA9884, a Novel Smad3-Dependent LncRNA, Promotes Diabetic Kidney Injury in db/db Mice Via Enhancing MCP-1-Dependent Renal Inflammation
- (2019) Ying-ying Zhang et al. DIABETES
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Deletion of Smad3 prevents renal fibrosis and inflammation in type 2 diabetic nephropathy
- (2019) Bi-Hua Xu et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The preventive and therapeutic implication for renal fibrosis by targetting TGF-β/Smad3 signaling
- (2018) Yun Zhang et al. CLINICAL SCIENCE
- The role of renal dipeptidyl peptidase-4 in kidney disease: renal effects of dipeptidyl peptidase-4 inhibitors with a focus on linagliptin
- (2018) Keizo Kanasaki CLINICAL SCIENCE
- A Genome-Wide Association Study of Diabetic Kidney Disease in Subjects With Type 2 Diabetes
- (2018) Natalie R. van Zuydam et al. DIABETES
- Transforming growth factor-β signalling in renal fibrosis: from Smads to non-coding RNAs
- (2018) Patrick Ming-Kuen Tang et al. JOURNAL OF PHYSIOLOGY-LONDON
- Thrombospondin-1 regulation of latent TGF-β activation: A therapeutic target for fibrotic disease
- (2018) Joanne E. Murphy-Ullrich et al. MATRIX BIOLOGY
- TGF-β Mediates Renal Fibrosis via the Smad3-Erbb4-IR Long Noncoding RNA Axis
- (2018) Min Feng et al. MOLECULAR THERAPY
- JAK1/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a Phase 2 randomized controlled clinical trial
- (2018) Katherine R Tuttle et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Specific Inhibitor of Smad3 (SIS3) Attenuates Fibrosis, Apoptosis, and Inflammation in Unilateral Ureteral Obstruction Kidneys by Inhibition of Transforming Growth Factor β (TGF-β)/Smad3 Signaling
- (2018) Xingli Ji et al. MEDICAL SCIENCE MONITOR
- NLRP3 deficiency ameliorates renal inflammation and fibrosis in diabetic mice
- (2018) Ming Wu et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- SIRT3 deficiency leads to induction of abnormal glycolysis in diabetic kidney with fibrosis
- (2018) Swayam Prakash Srivastava et al. Cell Death & Disease
- Long noncoding RNA lnc-TSI inhibits renal fibrogenesis by negatively regulating the TGF-β/Smad3 pathway
- (2018) Peng Wang et al. Science Translational Medicine
- Chinese Herbal Medicine Improves the Long-Term Survival Rate of Patients With Chronic Kidney Disease in Taiwan: A Nationwide Retrospective Population-Based Cohort Study
- (2018) Kuo-Chin Huang et al. Frontiers in Pharmacology
- Anti–TGF-β1 Antibody Therapy in Patients with Diabetic Nephropathy
- (2016) James Voelker et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Efficacy of statins in patients with diabetic nephropathy: a meta-analysis of randomized controlled trials
- (2016) Xue Shen et al. Lipids in Health and Disease
- Empagliflozin and Progression of Kidney Disease in Type 2 Diabetes
- (2016) Christoph Wanner et al. NEW ENGLAND JOURNAL OF MEDICINE
- Non-Smad Signaling Pathways of the TGF-β Family
- (2016) Ying E. Zhang Cold Spring Harbor Perspectives in Biology
- Oral Administration of N-Acetyl-seryl-aspartyl-lysyl-proline Ameliorates Kidney Disease in Both Type 1 and Type 2 Diabetic Mice via a Therapeutic Regimen
- (2016) Kyoko Nitta et al. Biomed Research International
- Review of Herbal Traditional Chinese Medicine for the Treatment of Diabetic Nephropathy
- (2016) Guang-dong Sun et al. Journal of Diabetes Research
- Therapeutic Effects of Tangshen Formula on Diabetic Nephropathy in Rats
- (2016) TingTing Zhao et al. PLoS One
- Effect of Antifibrotic MicroRNAs Crosstalk on the Action of N-acetyl-seryl-aspartyl-lysyl-proline in Diabetes-related Kidney Fibrosis
- (2016) Swayam Prakash Srivastava et al. Scientific Reports
- Renoprotective effect of berberine on type 2 diabetic nephropathy in rats
- (2015) Si-Fan Sun et al. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Efficacy and Safety of Tangshen Formula on Patients with Type 2 Diabetic Kidney Disease: A Multicenter Double-Blinded Randomized Placebo-Controlled Trial
- (2015) Ping Li et al. PLoS One
- Low TGFβ1 expression prevents and high expression exacerbates diabetic nephropathy in mice
- (2015) Catherine K. Hathaway et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Treatment of renal fibrosis by rebalancing TGF-β/Smad signaling with the combination of asiatic acid and naringenin
- (2015) Xiao-ming Meng et al. Oncotarget
- Smad7 protects against chronic aristolochic acid nephropathy in mice
- (2015) Xiao-Yu Dai et al. Oncotarget
- TGF-β/Smad signaling in renal fibrosis
- (2015) Xiao-Ming Meng et al. Frontiers in Physiology
- microRNA-29b prevents liver fibrosis by attenuating hepatic stellate cell activation and inducing apoptosis through targeting PI3K/AKT pathway
- (2015) Jia Wang et al. Oncotarget
- Smad7 inhibits AngII-mediated hypertensive nephropathy in a mouse model of hypertension
- (2014) Guan-Xian Liu et al. CLINICAL SCIENCE
- DPP-4 Inhibitors—Renoprotection in Diabetic Nephropathy?
- (2014) Usha Panchapakesan et al. DIABETES
- Linagliptin-Mediated DPP-4 Inhibition Ameliorates Kidney Fibrosis in Streptozotocin-Induced Diabetic Mice by Inhibiting Endothelial-to-Mesenchymal Transition in a Therapeutic Regimen
- (2014) Keizo Kanasaki et al. DIABETES
- miR-29b as a Therapeutic Agent for Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-β/Smad3 signaling
- (2014) Yang Zhang et al. MOLECULAR THERAPY
- N-acetyl-seryl-aspartyl-lysyl-proline: a valuable endogenous anti-fibrotic peptide for combating kidney fibrosis in diabetes
- (2014) Keizo Kanasaki et al. Frontiers in Pharmacology
- Identification of Novel Long Noncoding RNAs Associated with TGF-β/Smad3-Mediated Renal Inflammation and Fibrosis by RNA Sequencing
- (2013) Qin Zhou et al. AMERICAN JOURNAL OF PATHOLOGY
- Lack of specificity of fibroblast-specific protein 1 in cardiac remodeling and fibrosis
- (2013) Ping Kong et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- miR-21 is a key therapeutic target for renal injury in a mouse model of type 2 diabetes
- (2013) X. Zhong et al. DIABETOLOGIA
- Transforming growth factor-β1-mediated renal fibrosis is dependent on the regulation of transforming growth factor receptor 1 expression by let-7b
- (2013) Bo Wang et al. KIDNEY INTERNATIONAL
- MicroRNA-29b Inhibits Diabetic Nephropathy in db/db Mice
- (2013) Hai-Yong Chen et al. MOLECULAR THERAPY
- Primary aldosteronism and impaired natriuresis in mice underexpressing TGF 1
- (2013) M. Kakoki et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Circulating TGF-β1, Glycation, and Oxidation in Children with Diabetes Mellitus Type 1
- (2012) Vladimír Jakuš et al. Experimental Diabetes Research
- Intracellular redox equilibrium is essential for the constitutive expression of AP-1 dependent genes in resting cells: Studies on TGF-β1 regulation
- (2012) Marta González-Ramos et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Inflammasome-Independent NLRP3 Augments TGF- Signaling in Kidney Epithelium
- (2012) W. Wang et al. JOURNAL OF IMMUNOLOGY
- Inhibiting MicroRNA-192 Ameliorates Renal Fibrosis in Diabetic Nephropathy
- (2012) S. Putta et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- miR-29 Inhibits Bleomycin-induced Pulmonary Fibrosis in Mice
- (2012) Jun Xiao et al. MOLECULAR THERAPY
- Modular regulatory principles of large non-coding RNAs
- (2012) Mitchell Guttman et al. NATURE
- MicroRNA-21 Promotes Fibrosis of the Kidney by Silencing Metabolic Pathways
- (2012) B. N. Chau et al. Science Translational Medicine
- The TGFbeta Superfamily Signaling Pathway
- (2012) Alexander Weiss et al. Wiley Interdisciplinary Reviews-Developmental Biology
- Protection from Obesity and Diabetes by Blockade of TGF-β/Smad3 Signaling
- (2011) Hariom Yadav et al. Cell Metabolism
- Transforming growth factor-β/Smad signalling in diabetic nephropathy
- (2011) Hui Yao Lan CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
- Kidney-targeting Smad7 gene transfer inhibits renal TGF-β/MAD homologue (SMAD) and nuclear factor κB (NF-κB) signalling pathways, and improves diabetic nephropathy in mice
- (2011) S. M. Ka et al. DIABETOLOGIA
- Diverse roles of TGF-β receptor II in renal fibrosis and inflammation in vivo and in vitro
- (2011) Xiao-Ming Meng et al. JOURNAL OF PATHOLOGY
- TGF- /Smad3 Signaling Promotes Renal Fibrosis by Inhibiting miR-29
- (2011) W. Qin et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Smad3-Mediated Upregulation of miR-21 Promotes Renal Fibrosis
- (2011) X. Zhong et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Disruption of Smad4 impairs TGF-β/Smad3 and Smad7 transcriptional regulation during renal inflammation and fibrosis in vivo and in vitro
- (2011) Xiao-Ming Meng et al. KIDNEY INTERNATIONAL
- miR-200a Prevents Renal Fibrogenesis Through Repression of TGF- 2 Expression
- (2010) B. Wang et al. DIABETES
- Blockade of Endothelial-Mesenchymal Transition by a Smad3 Inhibitor Delays the Early Development of Streptozotocin-Induced Diabetic Nephropathy
- (2010) J. Li et al. DIABETES
- The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
- (2010) H. Y. Chen et al. DIABETES
- High glucose down-regulates miR-29a to increase collagen IV production in HK-2 cells
- (2010) Bin Du et al. FEBS LETTERS
- Loss of MicroRNA-192 Promotes Fibrogenesis in Diabetic Nephropathy
- (2010) A. Krupa et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- miR-192 Mediates TGF- /Smad3-Driven Renal Fibrosis
- (2010) A. C. K. Chung et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Smad2 Protects against TGF- /Smad3-Mediated Renal Fibrosis
- (2010) X. M. Meng et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The NLRP3 Inflammasome Promotes Renal Inflammation and Contributes to CKD
- (2010) A. Vilaysane et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- The immunogenicity of humanized and fully human antibodies
- (2010) Fiona A. Harding et al. mAbs
- The emerging role of TGF-β superfamily coreceptors in cancer
- (2009) Carmelo Bernabeu et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Angiotensin II Induces Connective Tissue Growth Factor and Collagen I Expression via Transforming Growth Factor–β–Dependent and –Independent Smad Pathways
- (2009) Fuye Yang et al. HYPERTENSION
- Advanced Glycation End-Products Induce Tubular CTGF via TGF- -Independent Smad3 Signaling
- (2009) A. C.K. Chung et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- MicroRNA-377 is up-regulated and can lead to increased fibronectin production in diabetic nephropathy
- (2008) Qiang Wang et al. FASEB JOURNAL
- Disruption of the Smad7 gene promotes renal fibrosis and inflammation in unilateral ureteral obstruction (UUO) in mice
- (2008) A. C. K. Chung et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Oral administration of GW788388, an inhibitor of TGF-β type I and II receptor kinases, decreases renal fibrosis
- (2007) M. Petersen et al. KIDNEY INTERNATIONAL
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started